Clinical Trial Update: Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1 [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 study evaluating the safety and efficacy of OPM-101 combined with anti-PD-1 in advanced melanoma that has shown resistance to anti-PD-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Anti-PD-1
• OPM-101

Snippet

Sponsor: Oncodesign Precision Medicine | Conditions: Advanced Melanoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING